Job ID: 581579261
Job date: 2018-04-15
End Date:
Company : Guardant Health Country : Role : Research Scientist
Job date: 2018-04-15
End Date:
Company : Guardant Health Country : Role : Research Scientist
Job Description:
As a member of the Bioinformatics development group, you will design wet lab studies, retrospective analyses, and simulations, develop and execute bioinformatics analysis plans, and author development reports. You will work closely with multiple teams across Guardant Health, including Bioinformatics, Software, Technology Development, Regulatory, and Operations. Your work will evaluate feasibility and reduce technical risk for development of critical features and studies in support of in-vitro diagnostic product development.
Additional Info:
Redwood City, CA About the Company: We believe conquering cancer is a big data problem. That’s why we built the world’s leading comprehensive liquid biopsy. This non-invasive tool for accessing and sequencing tumor DNA is used by thousands of oncologists to help tens of thousands of advanced cancer patients. We believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. We’re developing groundbreaking cancer in vitro diagnostic (IVD) tests that meet or exceed regulatory requirements in order to offer patients safe, effective, and timely diagnostic results that enable the most effective personalized therapies. We’ve raised more than $500 million from investors including Sequoia Capital, Khosla Ventures, OrbiMed, and SoftBank. At Guardant Health, we are committed to positively and significantly impacting patient health through technology breakthroughs that address long-standing unmet needs in oncology[Click Here to Access the Original Job Post]
As a member of the Bioinformatics development group, you will design wet lab studies, retrospective analyses, and simulations, develop and execute bioinformatics analysis plans, and author development reports. You will work closely with multiple teams across Guardant Health, including Bioinformatics, Software, Technology Development, Regulatory, and Operations. Your work will evaluate feasibility and reduce technical risk for development of critical features and studies in support of in-vitro diagnostic product development.
Qualifications
As a competitive candidate, you will have many of the the following training, skills, and experience:- PhD in Bioinformatics, Statistics, Computational Biology, Cancer Genomics, or related quantitative field
- Or MS in above + 3 years industry experience
- Experience designing, analyzing, troubleshooting, and visualizing wet lab experiments
- Demonstrable expertise in genome scale data analysis
- Bioinformatics skills in genomics, sequence analysis, python or R scripting under version control
- Awareness and experience with current landscape of bioinformatics tools
- Working knowledge of statistical methods, including: conditional probability, linear modeling, goodness-of-fit tests, maximum likelihood, and bayesian models.
- Attention to detail, with ability to write development reports
- Commitment to reproducible research
- IVD development experience in molecular diagnostics preferred
- Desire to contribute to personalized medicine and innovative cancer care
- Ability to work under fast-paced startup environment
- Work closely with molecular biologists to design and analyze feature development and feasibility experiments under design control
- Develop and execute bioinformatics analysis plans with testable acceptance criteria
- Conduct feasibility analyses and write development reports
- Identify and solve problems proactively as needed
Requeriments :
Skills :
Areas :
Additional Info:
Redwood City, CA About the Company: We believe conquering cancer is a big data problem. That’s why we built the world’s leading comprehensive liquid biopsy. This non-invasive tool for accessing and sequencing tumor DNA is used by thousands of oncologists to help tens of thousands of advanced cancer patients. We believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. We’re developing groundbreaking cancer in vitro diagnostic (IVD) tests that meet or exceed regulatory requirements in order to offer patients safe, effective, and timely diagnostic results that enable the most effective personalized therapies. We’ve raised more than $500 million from investors including Sequoia Capital, Khosla Ventures, OrbiMed, and SoftBank. At Guardant Health, we are committed to positively and significantly impacting patient health through technology breakthroughs that address long-standing unmet needs in oncology[Click Here to Access the Original Job Post]